Related Experiment Videos
Severe classical congenital muscular dystrophy and merosin expression
J Vajsar1, D Chitayat, L E Becker
1Division of Neurology, The Hospital for Sick Children and the University of Toronto, Ont., Canada.
Clinical Genetics
|October 27, 1998
Summary
Merosin deficiency is rare in congenital muscular dystrophy (CMD) and not always linked to severe cases. Merosin-positive CMD patients can also show severe muscle weakness, challenging previous assumptions.
Area of Science:
- Neuromuscular Disorders
- Genetics and Molecular Biology
- Pediatric Neurology
Background:
- Congenital muscular dystrophy (CMD) classification often distinguishes between merosin-deficient and merosin-positive forms.
- Autosomal recessive merosin-deficient CMD was previously thought to represent a homogeneous, severe subgroup.
Observation:
- Examined muscle biopsies from five children with severe classical CMD.
- Merosin deficiency was identified in only one patient with abnormal brain myelination.
- Four merosin-positive cases presented with severe muscle weakness and normal brain imaging.
Findings:
- Merosin-deficient CMD cases were infrequent in this cohort, contrary to prior reports.
- Severe muscle weakness was observed in merosin-positive CMD patients, indicating a severe phenotype is not exclusive to merosin deficiency.
- A potential autosomal dominant inheritance pattern was suggested in one family.
Implications:
- The absence of merosin in neonates with hypotonia and weakness can aid in early CMD diagnosis, even with non-specific histology.
- Clinical severity in CMD is not solely determined by merosin expression.
- Re-evaluation of CMD classification based on merosin status may be warranted.